Policy Statement NORD letter in support of California Senate Bill 643, a bill to add Duchenne muscular dystrophy to the list of medical conditions eligible for the Genetically Handicapped Persons Program
Policy Statement NORD letter in support of Iowa House File 233, an act regarding step therapy protocols
Policy Statement Coalition letter urging Congress to include funding to combat Zika in Fiscal Year 2018 appropriations
Policy Statement NORD letter in support of Florida House Bill 963, an act regarding newborn screening
Policy Statement NORD letter in support of Nevada Assembly Bill 245, an act calling for prescriber communication with regard to biosimilars
Policy Statement NORD letter in support of Kansas House Bill 2107, an act calling for prescriber communication with regard to biosimilars
Policy Statement American Plasma Users Coalition (APLUS) letter to Congress regarding patient protections
Policy Statement Coalition for Accessible Treatments (CAT) letter to Congress regarding ACA Cost Sharing
Policy Statement Coalition letter in support of CT HB 7118, an act calling for prescriber communication with regard to biosimilars
Policy Statement NORD letter in support of Alabama House Bill 82, an act calling for prescriber communication with regard to biosimilars
Policy Statement Coalition letter urging Congress to preserve funding for programs that provide critical support to state newborn screening programs
Policy Statement Coalition letter to New Jersey Legislature regarding patient out-of-pocket costs for prescription medications
Policy Statement NORD letter in support of New Mexico Senate Bill 180 and House Bill 260, acts calling for prescriber communication with regard to biosimilars
Policy Statement NORD letter in support of South Carolina Senate Bill 299 and South Carolina House Bill 3438
Policy Statement NORD joined coalition letters to the New York Assembly in support of A8246/S6303 to ensure all prescription copayments count towards patient cost-sharing obligations